MBNKF yields 144.93% · JNJ yields 2.13%● Live data
📍 MBNKF pulled ahead of the other in Year 1
Combined, MBNKF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MBNKF + JNJ for your $10,000?
Metro Bank PLC, together with its subsidiaries, provides retail and commercial banking services in the United Kingdom. The company offers personal banking products and services, including current, cash, and savings accounts; residential mortgages; credit cards and personal loans; pet insurance; and safe deposit box services. It also provides business banking products and services comprising business bank, commercial and community current, foreign currency, and insolvency practitioner accounts; deposit accounts, including business and community instant access deposit and fixed term deposit, business notice account, client premium and flexible client term deposit, and business loan calculator accounts; business and commercial loans and overdrafts, asset and invoice financing, bounce back loan, and recovery loan scheme. In addition, the company offers private banking services, such as private bank, saving, foreign currency, and money management accounts; and partnership loans, overdrafts, unsecured consumer lending, automotive finance, and digital lending products for SMEs. Metro Bank PLC was incorporated in 2007 and is headquartered in London, the United Kingdom.
Full MBNKF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.